TY - JOUR
T1 - Associations of race-ethnicity and history of traumatic brain injury with age at onset of alzheimer’s disease
AU - Chase Bailey, K.
AU - Burmaster, Sandra A.M.S.
AU - Schaffert, Jeff M.S.
AU - Lobue, Christian
AU - Vela, Daniela
AU - Rossetti, Heidi
AU - Munro Cullum, C.
N1 - Funding Information:
Supported in part by the University of Texas Southwestern Alzheimer’s Disease Center (NIH grant P30 AG12300) and the Texas Alzheimer’s Research and Care Consortium. The National Alzheimer’s Coordinating Center (NACC) database is funded by grant U01 AG016976 from the National Institute on Aging (NIA). NACC data were contributed by the following NIA-funded Alzheimer’s Disease Centers: P30 AG019610 (principal investigator, Eric Reiman, M.D.), P30 AG013846 (principal investigator, Neil Kowall, M.D.), P50 AG008702 (principal investiga-tor, Scott Small, M.D.), P50 AG025688 (principal investigator, Allan Levey, M.D., Ph.D.), P50 AG047266 (principal investigator, Todd Golde, M.D., Ph.D.), P30 AG010133 (principal investigator, Andrew Saykin, Psy.D.), P50 AG005146 (principal investigator, Marilyn Albert, Ph.D.), P50 AG005134 (principal investigator, Bradley Hyman, M.D., Ph.D.), P50 AG016574 (principal investigator, Ronald Petersen, M.D., Ph.D.), P50 AG005138 (principal investigator, Mary Sano, Ph.D.), P30 AG008051 (principal investigator, Thomas Wisniewski, M.D.), P30 AG013854 (principal investigator, M. Marsel Mesulam, M.D.), P30 AG008017 (principal investigator, Jeffrey Kaye, M.D.), P30 AG010161 (principal investigator, David Bennett, M.D.), P50 AG047366 (principal investigator, Victor Henderson, M.D., MS), P30 AG010129 (principal investigator, Charles DeCarli, M.D.), P50 AG016573 (principal investigator, Frank LaFerla, Ph.D.), P50 AG005131 (principal investigator, James Brewer, M.D., Ph.D.), P50 AG023501 (principal investigator, Bruce Miller, M.D.), P30 AG035982 (principal investigator, Russell Swerdlow, M.D.), P30 AG028383 (principal investigator, Linda Van Eldik, Ph.D.), P30 AG053760 (principal investigator, Henry Paulson, M.D., Ph.D.), P30 AG010124 (principal investigator, John Trojanowski, M.D., Ph.D.), P50 AG005133 (principal investigator, Oscar Lopez, M.D.), P50 AG005142 (principal investigator, Helena Chui, M.D.), P30 AG012300 (principal investigator, Roger Rosenberg, M.D.), P30 AG049638 (principal investigator, Suzanne Craft, Ph.D.), P50 AG005136 (principal investigator, Thomas Grabowski, M.D.), P50 AG033514 (principal investigator, Sanjay Asthana, M.D., F.R.C.P.), P50 AG005681 (principal investigator, John Morris, M.D.), and P50 AG047270 (principal investigator, Stephen Strittmatter, M.D., Ph.D.).
Funding Information:
The Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas (Bailey, Burmaster, Schaffert, LoBue, Vela, Rossetti, Cullum); and the Department of Neurological Surgery, University of Texas Southwestern Medical Center, Dallas (LoBue, Cullum). Send correspondence to Dr. Bailey (KennethC.Bailey@UTSouthwestern. edu). Supported in part by the University of Texas Southwestern Alzheimer’s Disease Center (NIH grant P30 AG12300) and the Texas Alzheimer’s Research and Care Consortium. The National Alzheimer’s Coordinating Center (NACC) database is funded by grant U01 AG016976 from the National Institute on Aging (NIA). NACC data were contributed by the following NIA-funded Alzheimer’s Disease Centers: P30 AG019610 (principal investigator, Eric Reiman, M.D.), P30 AG013846 (principal investigator, Neil Kowall, M.D.), P50 AG008702 (principal investigator, Scott Small, M.D.), P50 AG025688 (principal investigator, Allan Levey, M.D., Ph.D.), P50 AG047266 (principal investigator, Todd Golde, M.D., Ph.D.), P30 AG010133 (principal investigator, Andrew Saykin, Psy.D.), P50 AG005146 (principal investigator, Marilyn Albert, Ph.D.), P50 AG005134 (principal investigator, Bradley Hyman, M.D., Ph.D.), P50 AG016574 (principal investigator, Ronald Petersen, M.D., Ph.D.), P50 AG005138 (principal investigator, Mary Sano, Ph.D.), P30 AG008051 (principal investigator, Thomas Wisniewski, M.D.), P30 AG013854 (principal investigator, M. Marsel Mesulam, M.D.), P30 AG008017 (principal investigator, Jeffrey Kaye, M.D.), P30 AG010161 (principal investigator, David Bennett, M.D.), P50 AG047366 (principal investigator, Victor Henderson, M.D., MS), P30 AG010129 (principal investigator, Charles DeCarli, M.D.), P50 AG016573 (principal investigator, Frank LaFerla, Ph.D.), P50 AG005131 (principal investigator, James Brewer, M.D., Ph.D.), P50 AG023501 (principal investigator, Bruce Miller, M.D.), P30 AG035982 (principal investigator, Russell Swerdlow, M.D.), P30 AG028383 (principal investigator, Linda Van Eldik, Ph.D.), P30 AG053760 (principal investigator, Henry Paulson, M.D., Ph.D.), P30 AG010124 (principal investigator, John Trojanowski, M.D., Ph.D.), P50 AG005133 (principal investigator, Oscar Lopez, M.D.), P50 AG005142 (principal investigator, Helena Chui, M.D.), P30 AG012300 (principal investigator, Roger Rosenberg, M.D.), P30 AG049638 (principal investigator, Suzanne Craft, Ph.D.), P50 AG005136 (principal investigator, Thomas Grabowski, M.D.), P50 AG033514 (principal investigator, Sanjay Asthana, M.D., F.R.C.P.), P50 AG005681 (principal investigator, John Morris, M.D.), and P50 AG047270 (principal investigator, Stephen Strittmatter, M.D., Ph.D.). The authors report no financial relationships with commercial interests. Received January 2, 2019; revisions received April 17 and June 12, 2019; accepted June 17, 2019; published online Oct. 17, 2019.
Publisher Copyright:
© 2020, American Psychiatric Association. All rights reserved.
PY - 2020/6/1
Y1 - 2020/6/1
N2 - Objective: This study examined whether a history of traumatic brain injury (TBI) is associated with age at onset of Alzheimer’s disease (AD) in three racial-ethnic groups. Methods: Data from 7,577 non-Hispanic Caucasian, 792 African American, and 870 Hispanic participants with clinically diagnosed AD were obtained from the National Alzheimer’s Coordinating Center. Participants were categorized by the presence or absence of self-reported remote history of TBI (>1 year before diagnosis of AD) with loss of consciousness (LOC) (TBI+) or no history of TBI with LOC (TBI–). Any group differences in education; sex; APOE ε4 alleles; family history of dementia; or history of depression, stroke, hypertension, hypercholesterolemia, and diabetes were included in analyses of covariance comparing clinician-estimated age at AD symptom onset for the TBI+ and TBI– groups. Results: AD onset occurred 2.3 years earlier for non-Hispanic Caucasians (F=30.49, df=1, 7,572, p<0.001) and 3.4 years earlier for African Americans (F=5.17, df=1, 772, p=0.023) in the TBI+ group. In the Hispanic cohort, females in the TBI+ group had AD onset 5.6 years earlier, compared with females in the TBI– group (F=6.96, df=1, 865, p=0.008); little difference in age at AD onset was observed for Hispanic males with and without a TBI history. Conclusions: A history of TBI with LOC was associated with AD onset 2–3 years earlier in non-Hispanic Caucasians and African Americans and an onset nearly 6 years earlier in Hispanic females; no association was observed in Hispanic males. Further work in underserved populations is needed to un-derstand possible underlying mechanisms for these differences.
AB - Objective: This study examined whether a history of traumatic brain injury (TBI) is associated with age at onset of Alzheimer’s disease (AD) in three racial-ethnic groups. Methods: Data from 7,577 non-Hispanic Caucasian, 792 African American, and 870 Hispanic participants with clinically diagnosed AD were obtained from the National Alzheimer’s Coordinating Center. Participants were categorized by the presence or absence of self-reported remote history of TBI (>1 year before diagnosis of AD) with loss of consciousness (LOC) (TBI+) or no history of TBI with LOC (TBI–). Any group differences in education; sex; APOE ε4 alleles; family history of dementia; or history of depression, stroke, hypertension, hypercholesterolemia, and diabetes were included in analyses of covariance comparing clinician-estimated age at AD symptom onset for the TBI+ and TBI– groups. Results: AD onset occurred 2.3 years earlier for non-Hispanic Caucasians (F=30.49, df=1, 7,572, p<0.001) and 3.4 years earlier for African Americans (F=5.17, df=1, 772, p=0.023) in the TBI+ group. In the Hispanic cohort, females in the TBI+ group had AD onset 5.6 years earlier, compared with females in the TBI– group (F=6.96, df=1, 865, p=0.008); little difference in age at AD onset was observed for Hispanic males with and without a TBI history. Conclusions: A history of TBI with LOC was associated with AD onset 2–3 years earlier in non-Hispanic Caucasians and African Americans and an onset nearly 6 years earlier in Hispanic females; no association was observed in Hispanic males. Further work in underserved populations is needed to un-derstand possible underlying mechanisms for these differences.
UR - http://www.scopus.com/inward/record.url?scp=85084044879&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85084044879&partnerID=8YFLogxK
U2 - 10.1176/appi.neuropsych.19010002
DO - 10.1176/appi.neuropsych.19010002
M3 - Article
C2 - 31619118
AN - SCOPUS:85084044879
SN - 0895-0172
VL - 32
SP - 280
EP - 285
JO - Journal of Neuropsychiatry and Clinical Neurosciences
JF - Journal of Neuropsychiatry and Clinical Neurosciences
IS - 3
ER -